triclabendazole sulfoxide has been researched along with montelukast in 1 studies
Studies (triclabendazole sulfoxide) | Trials (triclabendazole sulfoxide) | Recent Studies (post-2010) (triclabendazole sulfoxide) | Studies (montelukast) | Trials (montelukast) | Recent Studies (post-2010) (montelukast) |
---|---|---|---|---|---|
30 | 1 | 16 | 1,965 | 598 | 777 |
Protein | Taxonomy | triclabendazole sulfoxide (IC50) | montelukast (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 3.197 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 4.702 | |
Beta-2 adrenergic receptor | Homo sapiens (human) | 3.488 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.689 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.919 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.434 | |
Cytochrome P450 2C8 | Homo sapiens (human) | 0.7 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 8.045 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 4.3 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.434 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 5.279 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 6.626 | |
Substance-K receptor | Homo sapiens (human) | 3.822 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.689 | |
Thromboxane-A synthase | Homo sapiens (human) | 1.525 | |
D(3) dopamine receptor | Homo sapiens (human) | 7.747 | |
Delta-type opioid receptor | Homo sapiens (human) | 4.795 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 6.256 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.434 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.601 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.856 | |
Leukotriene C4 synthase | Homo sapiens (human) | 5 | |
Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 0.0015 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR | 1 |
1 other study(ies) available for triclabendazole sulfoxide and montelukast
Article | Year |
---|---|
In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Topics: Acetates; Albendazole; Aldicarb; Biotransformation; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Methiocarb; Microsomes, Liver; Piperazines; Quinolines; Risk Assessment; Sulfides; Sulfones; Sulfoxides; Thiazoles; Triclabendazole | 2018 |